Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Gliatech (GLIA) -- Ignore unavailable to you. Want to Upgrade?

To: Dr. John M. de Castro who wrote (1527)	3/21/2000 4:21:00 PM
From: Ben Smith	Read Replies (1) \| Respond to of 2001

John, I took the application from IBM Intellectual Property Network, under Gliatech (http://patent.womplex.ibm.com/cgi-bin/patsearch). Since it was listed under Gliatech I assumed Gliatech would wind up with the patent. I thought it would be similar to Solomon Snyder with Johns Hopkins University and Guilford Pharmaceuticals with Serine Racemase. I should have checked with Gliatech first before posting. Sorry for posting something I was not positive about.

To: Dr. John M. de Castro who wrote (1527)	3/21/2000 5:55:00 PM
From: Ben Smith	Read Replies (1) \| Respond to of 2001

John, it looks like when I typed in Gliatech, the Boolean search mechanism brought up the patent because Gliatech is given as a reference. When you call up the patent ( patent.womplex.ibm.com, Gliatech is listed as the very last item under Other References: Gliatech, Inc. "Inhibition of Beta amyloid Binding to glycosaminoglycans for treatment of alzheimer's disease," WIPO International Publication No. WO 95/06477, Mar. 9 1995. (PCT/US94/09853, Filed Aug. 29 1994). I am embarrassed. A very embarrassing lesson that I will not soon forget. Thanks Rick for explaining. tom